International Journal of Hematology and Oncology 2022, Vol 32, Num 3 (Special Issue) Page(s): 024-028
Current Problems in the Management of Chronic Myeloid Leukemia in Turkey

Fatih DEMIRKAN

Dokuz Eylul University Faculty of Medicine, Department of Hematology, Izmir, TURKEY

Keywords: Chronic myeloid leukemia, Tyrosine kinase inhibitors, BCR/ABL
Although a large scale survey investigating the practice patterns of physicians for Chronic Myeloid Leukemia (CML) throughout Turkey is absent, there is an increasing enthusiasm on this subject after several years of experience with Tyrosine Kinase Inhibitors (TKI) therapy. Considering the problems in the management of CML patients, we can focus on deficiencies in the laboratory tests for diagnosis and monitoring, management of suboptimal response with imatinib therapy and conducting visit frequency of patients.